omega-n-methylarginine has been researched along with 1,3-dipropyl-8-cyclopentylxanthine in 5 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (1,3-dipropyl-8-cyclopentylxanthine) | Trials (1,3-dipropyl-8-cyclopentylxanthine) | Recent Studies (post-2010) (1,3-dipropyl-8-cyclopentylxanthine) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 1,301 | 1 | 165 |
| Protein | Taxonomy | omega-n-methylarginine (IC50) | 1,3-dipropyl-8-cyclopentylxanthine (IC50) |
|---|---|---|---|
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.0051 | |
| Adenosine receptor A3 | Rattus norvegicus (Norway rat) | 0.0038 | |
| Adenosine receptor A2a | Homo sapiens (human) | 0.2033 | |
| Adenosine receptor A2b | Homo sapiens (human) | 0.0234 | |
| Adenosine receptor A1 | Homo sapiens (human) | 0.0083 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Axe, FU; Bembenek, SD; Butler, CR; Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Karlsson, L; Lundeen, K; Riley, JP; Savall, BM; Tays, KL; Wei, J; Williams, KN; Xue, X | 1 |
| Boegehold, MA; Sauls, BA | 1 |
| Dennis, DM; Martynyuk, AE; Morey, TE; Rajasekaran, S | 1 |
| Garrison, RN; Harris, PD; Li, N; Matheson, PJ; Zakaria, el R | 1 |
| Althani, A; Fawzi, AA; Fituri, OM; Zakaria, el R | 1 |
5 other study(ies) available for omega-n-methylarginine and 1,3-dipropyl-8-cyclopentylxanthine
| Article | Year |
|---|---|
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Catalysis; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship | 2008 |
Adenosine linking reduced O2 to arteriolar NO release in intestine is not formed from extracellular ATP.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Arterioles; Enzyme Inhibitors; Extracellular Space; Intestine, Small; Male; Nitric Oxide; omega-N-Methylarginine; Oxygen; Rats; Rats, Sprague-Dawley; Vascular Patency; Vasoconstriction; Xanthines | 2001 |
Free radicals potentiate the negative dromotropic effect of adenosine in guinea pig isolated heart.
Topics: Adenosine; Animals; Anti-Arrhythmia Agents; Atrioventricular Node; Bundle of His; Female; Free Radicals; Guinea Pigs; Heart; In Vitro Techniques; Male; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Peroxynitrous Acid; Purinergic P1 Receptor Antagonists; Pyrogallol; Xanthines | 2003 |
Glucose-induced intestinal vasodilation via adenosine A1 receptors requires nitric oxide but not K(+)(ATP) channels.
Topics: Adenosine A1 Receptor Antagonists; Animals; Glucose; Glyburide; Hyperemia; Intestinal Absorption; Jejunum; KATP Channels; Male; Microscopy, Video; Microvessels; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Vasodilation; Xanthines | 2011 |
Molecular mechanisms of peritoneal dialysis-induced microvascular vasodilation.
Topics: Adenosine A1 Receptor Antagonists; Animals; Capillary Permeability; Dialysis Solutions; Diuretics, Osmotic; Endothelium, Vascular; Enzyme Inhibitors; Glucose; Glyburide; Hypoglycemic Agents; Ileum; Mannitol; Mefenamic Acid; omega-N-Methylarginine; Peritoneal Dialysis; Peritoneum; Rats; Vasodilation; Xanthines | 2014 |